Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
Public ClinicalTrials.gov record NCT00478192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIIb, Randomized, Double-Blind, Parallel Group, Multi-Center, Study to Assess the Efficacy and Safety of Multiple 30 Minute Infusions of YM087 (Conivaptan) in Subjects With Euvolemic or Hypervolemic Hyponatremia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is designed to assess the efficacy and safety of multiple infusions of conivaptan in subjects with euvolemic or hypervolemic hyponatremia
Study identification
- NCT ID
- NCT00478192
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2007
- Primary completion
- Jul 31, 2008
- Completion
- Jul 31, 2008
- Last update posted
- May 14, 2014
2007 – 2008
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Tucson | Arizona | 85723 | — |
| Not listed | Los Angeles | California | 90073 | — |
| Not listed | Denver | Colorado | 80218 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Port Charlotte | Florida | 33952 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Hazard | Kentucky | 41701 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | Omaha | Nebraska | 68198 | — |
| Not listed | The Bronx | New York | 10461 | — |
| Not listed | Cincinnati | Ohio | 45267 | — |
| Not listed | Fairfield | Ohio | 45014 | — |
| Not listed | Toledo | Ohio | 43606 | — |
| Not listed | Philadelphia | Pennsylvania | 19102 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Philadelphia | Pennsylvania | 19140 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Orangeburg | South Carolina | 29118 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00478192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2014 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00478192 live on ClinicalTrials.gov.